<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">China CDC Wkly</journal-id><journal-id journal-id-type="publisher-id">CCDCW</journal-id><journal-title-group><journal-title>China CDC Weekly</journal-title></journal-title-group><issn pub-type="epub">2096-7071</issn><publisher><publisher-name>Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention</publisher-name><publisher-loc>Beijing, China</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9433762</article-id><article-id pub-id-type="publisher-id">ccdcw-4-30-667</article-id><article-id pub-id-type="doi">10.46234/ccdcw2022.136</article-id><article-categories><subj-group subj-group-type="heading"><subject>Notes from the Field</subject></subj-group></article-categories><title-group><article-title>The First Outbreak of Omicron Subvariant BA.5.2 &#x02014; Beijing Municipality, China, July 4, 2022</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Zhaomin</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="fn1" ref-type="author-notes">&#x00026;</xref></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Ying</given-names></name><xref rid="aff2" ref-type="aff">2</xref><xref rid="fn1" ref-type="author-notes">&#x00026;</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Shuang</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Jia</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Shaohua</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Zhenquan</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Yunkui</given-names></name><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Fu</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Yang</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Quanyi</given-names></name><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Huo</surname><given-names>Da</given-names></name><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor1" ref-type="corresp">*</xref><email>huoda@bjcdc.org</email></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Institute for Infectious Disease and Endemic Disease Control, Beijing Center for Disease Prevention and Control, Beijing, China</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Office of Beijing Center for Global Health, Beijing Center for Disease Prevention and Control, Beijing, China</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Yanqing District Center for Disease Prevention and Control, Beijing, China</addr-line>
</aff><author-notes><corresp id="cor1">Da Huo, <email>huoda@bjcdc.org</email></corresp><fn id="fn1"><p>&#x00026;amp;&#x000a0;Joint&#x000a0;first&#x000a0;authors</p></fn></author-notes><pub-date pub-type="ppub"><day>29</day><month>7</month><year>2022</year></pub-date><volume>4</volume><issue>30</issue><fpage>667</fpage><lpage>668</lpage><history><date date-type="received"><day>11</day><month>7</month><year>2022</year></date><date date-type="accepted"><day>15</day><month>7</month><year>2022</year></date></history><permissions><copyright-statement>Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/">http://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link></license-p></license></permissions><kwd-group kwd-group-type="author-created"><kwd>SARS-CoV-2</kwd><kwd>Omicron subvariant</kwd><kwd>BA.5</kwd></kwd-group><funding-group><funding-statement>National Key Research and Development Program of China (2021ZD0114103)</funding-statement></funding-group></article-meta></front><body><p>On July 4, 2022, the first case of Omicron subvariant BA.5.2 in Beijing Municipality was discovered in Yanqing District. The case was a 49-year-old Chinese male who had arrived in Shanghai Municipality via international flight DL9927 from North Carolina, U.S. on June 15. He stayed in a hotel for the 14-day arrival quarantine and was discharged on June 30. He arrived in Beijing via domestic flight MU5103 on July 1 and was transferred point-to-point from the airport to his residence community in Yanqing District. On July 3, his sample was collected through community mass screening and reported positive the next morning. The case had received 3 doses of Moderna&#x02019;s mRNA vaccines in the U.S., with the last shot on May 26, 2022.</p><p>The index case caused an outbreak with a total of 16 cases located in 5 districts within 7 days. Among all cases, 12 were males and 4 were females; 12 received a booster shot, whereas 4 were non-vaccinated.</p><p>The respiratory samples from 16 cases were sequenced by the Next Generating Sequencing (NGS). A total of 13 full genomes were obtained and all belonged to the same lineage BA.5.2, Variant of Concern (VOC)/Omicron. In particular, 11 genomes shared a nucleotide similarity of 100%, 1 genome carried an additional mutation of T29678C, and 1 carried an additional heterozygous mutation of A6821G with a frequency of 59.39%. Phylogenetic analysis indicated the virus was similar to strains in North America, Europe, and Asia in mid-June, which was different from local clusters in Beijing in the same period (<xref rid="Figure1" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="Figure1"><label>Figure 1</label><caption><p>Neighbor-joining phylogenetic tree of strains in the outbreak.</p></caption><abstract abstract-type="note"><p>Note: The genomes from cases in the outbreak were indicated by red dots. The major VOC/Omicron PANGOLIN lineages were marked and colored on the right. The tree was rooted using strain Wuhan-1 (EPI_ISL_402125). </p><p>Abbreviation: VOC=variant of concern.</p></abstract><graphic xlink:href="ccdcw-4-30-667-1" position="float"/></fig><p>Omicron subvariant BA.5 had surged dramatically to become dominant in the U.S. (<xref rid="b1" ref-type="bibr">1</xref>). Research indicated that the Omicron BA.5 subvariant had a growth advantage against other subvariants with a higher ability of immune escape than the BA.1, BA.2, and BA.2.12.1 subvariants (<xref rid="b2" ref-type="bibr">2</xref>-<xref rid="b5" ref-type="bibr">5</xref>). Continuous surveillance and assessment need to be implemented to respond to the Omicron subvariant BA.5 in China.</p></body><back><ref-list><title>References</title><ref id="b1"><label>1</label><note><p>Center for Disease Control and Prevention. COVID Data Tracker, 10 July 2022. https://covid.cdc.gov/covid-data-tracker/#variant-proportions. [2022-7-11].</p></note></ref><ref id="b2"><label>2</label><note><p>Tegally H, Moir M, Everatt J, Giovanetti M, Scheepers C, Wilkinson E, et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med 2022. http://dx.doi.org/10.1038/s41591-022-01911-2. [2022-7-11].</p></note></ref><ref id="b3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author">Hachmann NP, Miller J, Collier ARY, Ventura JD, Yu JY, Rowe M, et al</person-group><article-title>Neutralization escape by SARS-CoV-2 Omicron subvariants BA</article-title><source>2.12.1, BA.4, and BA.5. N Engl J Med</source><year>2022</year><volume>387</volume><issue>1</issue><fpage>86</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1056/NEJMc2206576.</pub-id><pub-id pub-id-type="pmid">35731894</pub-id></element-citation></ref><ref id="b4"><label>4</label><note><p>Cao YL, Yisimayi A, Jian FC, Song WL, Xiao TH, Wang L, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 2022. http://dx.doi.org/10.1038/s41586-022-04980-y. [2022-7-11].</p></note></ref><ref id="b5"><label>5</label><note><p>Wang Q, Guo YC, Iketani S, Nair MS, Li ZT, Mohri H, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, &#x00026; BA.5. Nature 2022. http://dx.doi.org/10.1038/s41586-022-05053-w. [2022-7-11].</p></note></ref></ref-list></back></article>
